Home Newsletters Immunology of Infectious Disease News Pfizer Antiviral Slashes COVID-19 Hospitalizations

Pfizer Antiviral Slashes COVID-19 Hospitalizations

0
Opening a new chapter in the treatment of COVID-19—one borrowed from successfully tackling the AIDS virus—the drug behemoth Pfizer reported upbeat results for a 5-day pill regimen to treat early infections with SARS-CoV-2.
[ScienceInsider]

Sorry, but the selected Zotpress account can't be found.

Press Release
Exit mobile version